Finding the right medication dose is critical for safety and effectiveness. Learn how age, kidney function, genetics, and drug interactions affect your dose-and what steps you can take to avoid dangerous side effects.
Read More
Apixaban and rivaroxaban are safe and effective for obese patients at standard doses. Dabigatran increases GI bleeding risk in severe obesity. Edoxaban may need caution in extreme BMI. No need to increase doses.
Read More
Learn how to find your medical device or medication lot number, check for active recalls, and protect yourself using FDA tools and simple steps. Your safety depends on knowing what’s in your body.
Read More
Learn how to track symptoms linked to medications using a simple, evidence-based diary. Record timing, dosage, and reactions to help your doctor identify drug side effects faster and avoid misdiagnosis.
Read More
Learn how common medications can make your skin dangerously sensitive to sunlight, what to avoid, and how to protect yourself with proven sun safety strategies.
Read More
Learn how global systems like VigiBase and WHO PIDM track drug side effects across 170+ countries to protect public health, detect hidden risks, and ensure medicines remain safe after they're widely used.
Read More
Generic medications save billions in healthcare costs, but true value comes from adherence, real-world outcomes, and smart use - not just lower prices. Learn how HEOR reveals the full cost-benefit picture.
Read More
The FDA issued major drug safety alerts in 2025, including updated opioid warnings, MRI requirements for Alzheimer's drugs, and new risks for ADHD and allergy meds. Know what's changed and what to do next.
Read More
In 2025, the FDA issued record numbers of warning letters over manufacturing flaws like poor sterile controls, fake data, and contaminated ingredients. Learn the top 5 issues and how to avoid them.
Read More
COPD stages are based on lung function tests and symptoms. Learn what mild, moderate, and severe COPD really mean-and how to take action before it's too late.
Read More